CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
| Recalling firm | Heritage Pharmaceuticals Inc |
|---|---|
| Reason | Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles. |
| Risk class | Class II (Class II · moderate) |
| Status | Ongoing |
| Report date | Aug 19, 2026 |
| Initiated | Jul 30, 2026 |
| Region | NJ, United States |
| Distribution | Nationwide within the U.S |
| Code/Lot | Lot #: 2411550, Exp. 2026/NOV. |
| Type | Voluntary: Firm initiated |
| Recall number | D-0768-2026 |
Official source
U.S. FDA — Recalls, Market Withdrawals & Safety Alerts fda.gov ↗You can re-verify each item on the official FDA site using its recall number. (Recall number: D-0768-2026)
openFDA (U.S. Food & Drug Administration) — food/drug/device enforcement · CC0 1.0 (public domain)
Find out more
- Search this recall on FDA fda.gov ↗
- Search related news (Google News) news.google.com ↗
- Search this product (Google) google.com ↗
The links above open external searches by recall number / product name; the results are the responsibility of each site.
This page summarizes U.S. FDA data for general information and is not medical advice. Confirm details via official FDA announcements and the manufacturer.